Russ and all,
Here is some good news:
Monday September 29 4:51 PM EDT
Company Press Release
Pharmacopeia, Inc. Announces Extension of Research Collaboration with
Schering-Plough
PRINCETON, N.J., Sept. 29 /PRNewswire/ -- Pharmacopeia, Inc. (Nasdaq:PCOP) today announced that Schering-Plough Corporation
(NYSE:SGP) has elected to extend its research collaboration with Pharmacopeia. The collaboration originally focused on small molecule drug
discovery in the areas of cancer and asthma, and now includes a specific target in hepatitis. As a result of this extension, Schering-Plough will provide
Pharmacopeia with additional R&D funding. Specific financial terms were not disclosed.
Pharmacopeia and Schering-Plough initiated their drug discovery research collaboration on specific targets in cancer and asthma in December 1994.
The collaboration was first extended in October 1996. In 1997 the hepatitis program was added. This announcement marks the second extension of
the research collaboration.
``Our research programs with Schering-Plough are moving along very well,'' said Joseph A. Mollica, Ph.D., Chairman, President, and Chief
Executive Officer. ``In less than three years we were able to identify significant leads in our first two programs, i.e., cancer and asthma. We look
forward to our third program, in the area of hepatitis, meeting with similar success. We are pleased with Schering-Plough's continued confidence in
our company and our patented approach to drug discovery.'' |
